Damon Runyon News
View New Articles By
View New Articles By
(Bronx, NY) More than 2,150 people from across the country and abroad took part in the 11th Annual Runyon 5K at Yankee Stadium on Saturday, May 11, 2019, raising nearly $400,000 to support breakthrough cancer research by today’s best young scientists, funded by the Damon Runyon Cancer Research Foundation. Since the inaugural event in 2009, the annual Runyon 5K has raised more than $5.5 million.
(New York, NY) To help increase the number of physician-scientists, the Damon Runyon Cancer Research Foundation created the Damon Runyon Physician-Scientist Training Award, which provides physicians who have earned an MD degree and completed clinical specialty fellowship training the opportunity to gain the research experience they need to become leaders in translational and clinical research. Damon Runyon announced that six scientists with novel approaches to fighting cancer have been named the 2019 recipients of the award.
Guest Author: Marissa Rashkovan, PhD, Damon Runyon-Sohn Pediatric Cancer Fellow
On my 14th birthday, my parents sat my brother and me down and let us know that my mom had cancer – non-Hodgkin’s Lymphoma to be exact. At the time, I didn’t know what that was.
We recently hosted a Twitter chat with Damon Runyon Clinical Investigator, Joshua Brody, MD, of the Icahn School of Medicine at Mount Sinai to discuss his latest breakthrough - a promising new cancer vaccine that activates the immune system to fight tumors throughout the body. While Dr. Brody didn't have the time to answer all the questions about his exciting research during the hour-long Twitter chat, the full interview is presented here.
Damon Runyon Clinical Investigator Priscilla K. Brastianos, MD, is driven to find a cure for metastatic cancer. Dr. Brastianos’s grandmother was 23 years old when she felt a breast mass during medical school training and diagnosed herself with breast cancer, only to pass away at 29 when the cancer had metastasized to the spine. Four decades later, her mother faced the same devastating diagnosis. After living through therapy after therapy that failed, she lost the fight to breast cancer that had metastasized to the brain.
By Joseph D. Mancias, MD, PhD, Damon Runyon Rachleff-Innovator at the Dana-Farber Cancer Institute
At the recent Accelerating Cancer Cures Symposium in New York City, I got an inside look at the cutting-edge cancer research presented by fellow Damon Runyon scientists. The unique symposium encourages networking with fellow awardees and pharmaceutical industry leaders. Unlike solitary work in the lab, collaboration provides a synergy of ideas most likely to lead to unexpected paths of discovery.